Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 17, 2024 - Issue
Submit an article Journal homepage
68
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Case of Pustular Pyoderma Gangrenosum Misdiagnosed as Acute Febrile Neutrophilic Dermatosis in a Pediatric Patient

Xiaoli YangDepartment of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, People’s Republic of ChinaView further author information
,
Yongzhuo WuDepartment of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, People’s Republic of ChinaView further author information
,
Fuqiong JiangDepartment of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, People’s Republic of ChinaView further author information
&
Danqi DengDepartment of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 493-498 | Received 11 Nov 2023, Accepted 18 Feb 2024, Published online: 27 Feb 2024

References

  • Chateau A, Makhubele J, Dlova N. Corticosteroid wraps as monotherapy in a child with extensive idiopathic pyoderma gangrenosum. Pediatr Dermatol. 2021;38(1):184–186. doi:10.1111/pde.14348
  • Chen B, Li W, Qu B. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med. 2023;10:1134939. doi:10.3389/fmed.2023.1134939
  • Kechichian E, Haber R, Mourad N, El Khoury R, Jabbour S, Tomb R. Pediatric pyoderma gangrenosum: a systematic review and update. Int J Dermatol. 2017;56(5):486–495. doi:10.1111/ijd.13584
  • Schøsler L, Fogh K, Bech R. Pyoderma gangrenosum: a retrospective study of clinical charac-teristics, comorbidities, response to treatment and mortality related to prednisone dose. Acta Derm Venereol. 2021;101(4):adv00431. doi:10.2340/00015555-3776
  • Ashchyan HJ, Butler DC, Nelson CA, et al. The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol. 2018;154(4):409–413. doi:10.1001/jamadermatol.2017.5978
  • Haimes H, Corey K, Mostaghimi A, Schmidt B, Gellis SE, Liang MG. Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Pediatr Dermatol. 2020;37(4):764–766. doi:10.1111/pde.14186
  • Chen J, Wang H, Ren F. Dramatic case of paediatric pyoderma gangrenosum. Arch Dis Child. 2021;106(10):1001. doi:10.1136/archdischild-2020-320598
  • Vaidy K, Winderman R, Rabinowitz SS, Schwarz SM. Treatment of pyoderma gangrenosum in pediatric inflammatory bowel disease. JPGN Rep. 2020;1(2):e008. doi:10.1097/PG9.0000000000000008
  • Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800. doi:10.1111/j.1365-4632.2004.02128.x
  • Maverakis E, Ma C, Shinkai K, et al. Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts. JAMA Dermatol. 2018;154(4):461–466. doi:10.1001/jamadermatol.2017.5980

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.